Early Identification of Patients Who Benefit From Palbociclib in Addition to Letrozole
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Feb 2017
At a glance
- Drugs Palbociclib (Primary) ; Letrozole
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 14 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 18 Aug 2016 Status changed from not yet recruiting to recruiting.
- 23 Jun 2016 New trial record